TC | 
Stat | 
Stk | 
Ins | 
Fil | 
+d | 
+w | 
+m | 
+q | 
+h | 
+y | 
avg | 
				
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 5 | 5 | 1 | 1 | -9 | -12 | -22 | -6 | 
| S | %wins | 80 | 60 | 80 | 80 | 60 | 40 | 67 | 
Filing Date | 
					T Date | 
					Ticker | 
					Issuer | Inc | 					Sector | 
					Ind | Industry |  
						Owner | 
						oSt | 
						Rel | 
						Title | 
					 
					T | 
					TVal | 
					Price | 
					L | 
					Qty | 
					oc | 
					Own | 
					H | 
					r2y | 
					r1y | 
					r6m | 
					r3m | 
					r6w | 
					r3w | 
					r7d | 
					r3d | 
					f1d | 
					f1w | 
					f1m | 
					f3m | 
					f6m | 
					f1y | 
				
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/2/15 17:34  | 2/26/15  | OREX | Orexigen Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Booth Mark D | CA | O | Chief Co | S.d | -284 | 5.68 | 1 | -50 | -93 | 4 | D | 4 | -24 | -5 | -2 | 9 | 7 | -2 | -3 | 32 | 23 | 35 | -16 | -54 | -90 | 
7/29/13 19:50  | 7/26/13  | OREX | Orexigen Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Booth Mark D | CA | O | Chief Co | S.d | -489 | 7.55 | 1 | -65 | -100 | 0 | D | 349 | 32 | 29 | 18 | 18 | 23 | 20 | 13 | 0 | -1 | -5 | -28 | -13 | -34 | 
3/12/13 20:26  | 3/11/13  | OREX | Orexigen Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Booth Mark D | CA | O | Chief Co | S.d | -185 | 6.67 | 1 | -28 | -100 | 0 | D | 132 | 84 | 35 | 38 | 16 | 18 | 12 | 2 | -1 | -11 | -9 | -3 | 6 | 4 | 
1/18/13 06:02  | 1/15/13  | OREX | Orexigen Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Booth Mark D | CA | O | Chief Co | S.d | -149 | 6.67 | 1 | -22 | -100 | 0 | D | -34 | 217 | -12 | 4 | 35 | 22 | 6 | 0 | -4 | -8 | -10 | -1 | 5 | 9 | 
6/29/12 18:58  | 6/28/12  | OREX | Orexigen Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Booth Mark D | CA | O | Chief Co | S.d | -585 | 5.66 | 2 | -103 | -100 | 0 | D | 40 | 273 | 269 | 30 | 65 | 75 | 51 | 45 | -4 | 4 | -7 | 3 | -5 | 3 | 
| D | Derivative transaction in filing (usually option exercise) | 
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price | 
| A | Amended filing | 
| E | Error detected in filing | 
| S - Sale | Sale of securities on an exchange or to another person | 
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) | 
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company | 
| P - Purchase | Purchase of securities on an exchange or from another person |